X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1831) 1831
Publication (137) 137
Book Review (17) 17
Book Chapter (12) 12
Magazine Article (10) 10
Conference Proceeding (6) 6
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1791) 1791
hematinics - therapeutic use (1092) 1092
index medicus (977) 977
female (964) 964
male (880) 880
anemia - drug therapy (839) 839
hematinics - adverse effects (788) 788
anemia (771) 771
middle aged (713) 713
hematinics - administration & dosage (667) 667
aged (597) 597
erythropoietin - therapeutic use (551) 551
recombinant proteins (491) 491
anemia - etiology (480) 480
treatment outcome (476) 476
adult (457) 457
epoetin alfa (413) 413
erythropoietin (402) 402
urology & nephrology (397) 397
erythropoietin - adverse effects (359) 359
recombinant-human-erythropoietin (359) 359
hemoglobins - metabolism (338) 338
darbepoetin alfa (312) 312
erythropoietin - analogs & derivatives (308) 308
erythropoietin - administration & dosage (307) 307
oncology (284) 284
chronic kidney-disease (278) 278
hemoglobin (262) 262
epoetin-alpha (261) 261
anemia - blood (259) 259
risk factors (258) 258
antineoplastic agents - adverse effects (256) 256
anemia - chemically induced (250) 250
double-blind (232) 232
neoplasms - drug therapy (221) 221
renal dialysis - adverse effects (220) 220
aged, 80 and over (215) 215
mortality (214) 214
quality-of-life (213) 213
kidney failure, chronic - therapy (211) 211
kidney failure, chronic - complications (210) 210
care and treatment (208) 208
anemia, iron-deficiency - drug therapy (207) 207
hemoglobins - analysis (207) 207
cancer (205) 205
quality of life (200) 200
pharmacology & pharmacy (197) 197
time factors (190) 190
hemodialysis (189) 189
retrospective studies (186) 186
drug administration schedule (176) 176
prospective studies (174) 174
hemodialysis-patients (167) 167
medicine, general & internal (167) 167
renal dialysis (164) 164
iron (160) 160
chemotherapy (157) 157
therapy (153) 153
neoplasms - complications (151) 151
blood transfusion (150) 150
erythropoiesis-stimulating agents (145) 145
health aspects (144) 144
chronic kidney disease (141) 141
intravenous iron (141) 141
ferric compounds - administration & dosage (140) 140
dose-response relationship, drug (139) 139
renal insufficiency, chronic - complications (138) 138
darbepoetin-alpha (135) 135
research (134) 134
hematology (133) 133
drug therapy (129) 129
infusions, intravenous (129) 129
trial (125) 125
anemia - therapy (124) 124
adolescent (123) 123
nephrology (123) 123
randomized controlled trials as topic (122) 122
united states (122) 122
hematinics - pharmacology (119) 119
anemia, iron-deficiency - etiology (118) 118
biomarkers - blood (118) 118
erythropoiesis - drug effects (118) 118
ferritins - blood (117) 117
placebo-controlled trial (117) 117
practice guidelines as topic (115) 115
medicine & public health (112) 112
anaemia (111) 111
dialysis (111) 111
ferric compounds - adverse effects (108) 108
chronic kidney failure (105) 105
transplantation (105) 105
young adult (103) 103
animals (102) 102
hematinics - economics (101) 101
injections, intravenous (100) 100
double-blind method (99) 99
analysis (98) 98
epoetin (98) 98
antineoplastic agents - therapeutic use (97) 97
chronic disease (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1744) 1744
French (24) 24
Spanish (16) 16
German (12) 12
Hungarian (12) 12
Italian (11) 11
Japanese (11) 11
Croatian (4) 4
Dutch (3) 3
Russian (3) 3
Bulgarian (1) 1
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 03/2013, Volume 57, Issue 3, pp. 974 - 984
Journal Article
Kidney International, ISSN 0085-2538, 10/2015, Volume 88, Issue 4, pp. 905 - 914
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
In this trial, patients with systolic heart failure and anemia were assigned to receive either darbepoetin alfa or placebo. At 28 months, there was no... 
MORTALITY | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
The Lancet, ISSN 0140-6736, 2006, Volume 367, Issue 9505, pp. 133 - 143
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 25, pp. 2436 - 2448
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 1, pp. 159 - 169
Nephrology | UROLOGY & NEPHROLOGY | Humans | Pain Management | Diabetic Nephropathies - drug therapy | Metabolic Clearance Rate | Analgesics - pharmacokinetics | Renal Insufficiency, Chronic - complications | Renal Insufficiency, Chronic - metabolism | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Renal Insufficiency, Chronic - therapy | Anemia - drug therapy | Contrast Media - adverse effects | Drug Interactions | Patient Safety | Acute Kidney Injury - chemically induced | Anti-Bacterial Agents - adverse effects | Platelet Aggregation Inhibitors - pharmacokinetics | Platelet Aggregation Inhibitors - therapeutic use | Anemia - etiology | Kidney - physiopathology | Analgesics - adverse effects | Platelet Aggregation Inhibitors - adverse effects | Hypoglycemic Agents - therapeutic use | Medication Errors | Analgesics - therapeutic use | Arrhythmias, Cardiac - prevention & control | Hyperkalemia - complications | Hypoglycemic Agents - pharmacokinetics | Glomerular Filtration Rate | Hematinics - therapeutic use | Bacterial Infections - drug therapy | Hyperkalemia - physiopathology | Anticoagulants - therapeutic use | Hematinics - adverse effects | Renin-Angiotensin System - physiology | Arrhythmias, Cardiac - etiology | Gadolinium - adverse effects | Anticoagulants - adverse effects | Hyperkalemia - chemically induced | Renin-Angiotensin System - drug effects | Aged | Anticoagulants - pharmacokinetics | Iodine Compounds - adverse effects | Pharmacokinetics | Insulin - adverse effects | Insulin - therapeutic use
Journal Article
Journal Article
Journal Article